International Immunology, Vol. 16, No. 4, pp. 579-583,
April 2004
© 2004 Japanese Society for Immunology
Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn’s disease
1 Department of Experimental Biology, University of Jaén, Jaén, Spain 2 Service de Recherches en Hemato-Immunologie, Commissariat a l’Energie Atomique, Department de Recherche Medicale, Hopital Saint-Louis, Paris, France 3 Department of Cell Biology, University of Granada, Granada, Spain 4 Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain 5 Department of Biochemistry and Molecular Biology, University of Granada, Granada, Spain 6 Department of Paediatrics, Facultad de Medicina, University of Granada, Granada, Spain
Correspondence to: M. I. Torres; E-mail: mitorres{at}ujaen.es
Transmitting editor: A. Falus
In addition to being involved in nutrient uptake, the epithelial mucosa constitute the first line of defense against microbial pathogens. A direct consequence of this physiological function is a very complex network of immunological interactions that lead to a strong control of the mucosal immune balance. The dysfunction of immunological tolerance is likely to be a cause of inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s disease (CD). HLA-G is a non-classical major histocompatibility complex (HLA) class I molecule, which is highly expressed by human cytotrophoblast cells. These cells play a role in immune tolerance by protecting trophoblasts from being killed by uterine NK cells. Because of the deregulation of immune system activity in IBD, as well as the immunoregulatory role of HLA-G, we have analyzed the expression of HLA-G in intestinal biopsies of patients with UC and CD. Our study shows that the differential expression of HLA-G provides a potential way to distinguish between UC and CD. Although the reason for this differential expression is unclear, it might involve a different mechanism of immune regulation. In addition, we demonstrate that in the lamina propria of the colon of patients with UC, IL-10 is strongly expressed. In conclusion, the presence of HLA-G on the surface of intestinal epithelial cell in patients with UC lends support to the notion that this molecule may serve as a regulator of mucosal immune responses to antigens of undefined origin. Thus, this different pattern of HLA-G expression may help to differentiate between the immunopathogenesis of CD and UC.
Keywords: Crohn’s disease, HLA-G, inflammatory bowel disease, ulcerative colitis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Veit, E. Cordero, T Mucenic, O. Monticielo, J. Brenol, R. Xavier, A Delgado-Canedo, and J. Chies Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus Lupus, April 1, 2009; 18(5): 424 - 430. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Glas, H.-P. Torok, L. Tonenchi, M. Wetzke, V. Beynon, M. Y. Teshome, S. Cotofana, U. Schiemann, T. Griga, W. Klein, et al. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease Int. Immunol., May 1, 2007; 19(5): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Singh, P. E. Moore, J. E. Gern, R. F. Lemanske Jr., and T. V. Hartert Bronchiolitis to Asthma: A Review and Call for Studies of Gene-Virus Interactions in Asthma Causation Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 108 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M I Torres, M A Lopez-Casado, J Luque, J Pena, and A Rios New advances in coeliac disease: serum and intestinal expression of HLA-G Int. Immunol., May 1, 2006; 18(5): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Tan, A. M. Shon, and C. Ober Evidence of balancing selection at the HLA-G promoter region Hum. Mol. Genet., December 1, 2005; 14(23): 3619 - 3628. [Abstract] [Full Text] [PDF]
|
|